**4.2.6 Aflatoxin-albumin adduct in blood serum**

134 Health Management – Different Approaches and Solutions

aflatoxin, in humans, will now be discussed in terms of their role as markers of internal

Aflatoxin M1 is a predominant metabolite in human urine. The presence of aflatoxin M1 in urine may be detected by TLC, HPLC and ELIZA methods. Immunoaffinity columns have

Zhu et al. (1987) have compared dietary exposure to the aflatoxins with the urinary excretion of aflatoxin M1, over a 3-day period, by analysing 252 urine samples in Guangxi Region of China. Between 1.2 and 2.2% of the dietary aflatoxin B1 appeared in the urine as

The occurrence of aflatoxin M1 in human breast milk is both an indicator of exposure of individual mothers to aflatoxin in food, and of the exposure of their infants to this toxin. However, no studies have reported a good correlation between levels of ingested aflatoxin B1 and levels of aflatoxin M1 in human breast milk. The occurrence of aflatoxin M1 in human breast milk has been studied in Zimbabwe and France (Wild et al., 1987). In Zimbabwe , 11% of 54 samples of milk contained up to 0.05ug/L) aflatoxin M1, whereas none of the 42

Unmetabolised aflatoxin B1 in human blood serum has been used as an indicator of recent exposure to aflatoxins in food. Aflatoxin B1 has been detected (Tsuboi et al., 1984; Denning et al., 1988), for examples, in serum samples collected in Japan, Nigeria and Sudan. The

The aflatoxin M1, B1, B2, G1 and G2 have been detected in cord sera from Ghana (34% of 188 samples); and aflatoxin M1, M2 and in B2 cord sera collected in Nigeria (12% of 78 samples)

Two biomarkers of biologically effective dose have been developed. The first marker is a urinary aflatoxin B1 -DNA adduct whereas the second is an adduct between aflatoxin B1 and

Studies in rats have examined the urinary excretion kinetics of specific metabolites after a single exposure to aflatoxin B1-N7-guanine (the primary B1-DNA adduct (Figure 8) accounted for 7.5% of the total detectable aflatoxins, whereas the aflatoxins P1, Q1, M1 and B1 accounted for 31.5, 3,0, 2.2 and 0.3% of total aflatoxins, respectively (Groopman et al., 1992). Over the 24 hours after exposure, an excellent correlation existed between the oral dose of aflatoxin B1 and the urinary aflatoxin-N7-guanine adduct. The other metabolites

The use of the aflatoxin-albumin adduct as a marker of the biologically effective does offers two advantages over the measurement of the aflatoxin-DNA adduct. Firstly, whereas the

detection methods used were ELIZA and HPLC; up to 3ug/kg B1 were detected.

aflatoxin M1, with a good correlation between the ingestion and excreted toxins.

dose, biologically affective dose, early biological effect and susceptibility.

also been used to clean-up the samples prior to quantification.

samples collected in France was contaminated.

**4.2.4 Markers of biologically effective dose** 

**4.2.5 Aflatoxin B1-DNA adduct in urine** 

showed no such relationship.

**4.2 Markers of internal dose 4.2.1 Markers in urine** 

**4.2.2 Markers in milk** 

**4.2.3 Markers in blood** 

(Lamplugh et al., 1988).

serum protein.

The aflatoxin-albumin adduct has been measured in children and adults from a variety of African, and other countries. In Africa, between 12 and 100% of the samples contained the adduct, whereas samples from Thailand were contaminated at lower levels and incidence. An estimate of the average daily intake of aflatoxin B1 was performed by determining the aflatoxin-albumin adduct in blood samples collected from population of 100 persons attending health screening at the Bangladesh Institute of Research and Rehabillitation in Diabetes, Endocrine and Metabolic Disorders, BIRDEM) and United Kingdom. A comprehensive studies of the major foods showed that the main staples such as rice, pulses and wheat, were relatively free of mycotoxin contamination, whereas maize and groundnuts were significantly contaminated. Over 60% of the groundnut samples contained aflatoxin, with some samples containing levels of toxin which were 40 times greater than the maximal level permitted in the European Union, EU. About 70% of maize were contaminated, and 17% of these contained more than one mycotoxin; one sample contained five different mycotoxins. Since the use of maize, both as an animal feed and as human food, is being activiely encourage in Bangladesh, it is essential that every effort is made to alleviate the occurrence of mycotoxin in this commodity.

#### **4.3 Markers of early biological effect**

#### **4.3.1 Measures of mutation spectra**

Studies in the field of molecular biology have led to a better understanding of the generic alterations which occur during the progression from initiation to tumour formation, and to the development of sensitivity tests for the diagnosis of tumours.

The p53 tumour suppression gene is mutated in more than 50% of all human tumours (Hollstein et al., 1991). The number and type of mutations in this gene (the mutation spectrum) are not equally distributed, but occur in specific hot-spots which vary with the etiology of tumour formation.

In vitro studies using the human p53 gene have shown that codon 249 is the preferential site for the formation of aflatoxin-N7-guanine adducts (Pusieux et al., 1991). Exposure of cultured human liver cells to aflatoxin B1 has produced codon 249 mutations. Although the link between aflatoxin exposure and specific p53 gene mutations in human populations has still to be confirmed, the gene mutation spectrum has considerable potential as a marker for exposure to, and damage from, the aflatoxins.

#### **4.4 Markers of susceptibility**

#### **4.4.1 Measures of genetic variation in metabolism**

Susceptibility to a particular agent will be influenced by the ability of individuals to absorb, distribute and metabolize the agent, and the nature of the metabolic process. The ability of individuals to repair damage inflicted by the agent will also contribute to the level of susceptibility. Studies with human liver microsomes have shown that the cytochrome P450s involved in the activation (epoxidation) of aflatoxin B1 vary with the level of exposure. The activation of high levels of aflatoxin B1, for example, is performed by cytochrome P450 3A4

Mycotoxins: Quality Management, Prevention, Metabolism, Toxicity and Biomonitoring 137

Autrup, H., Essigmann, J.M., Croy, R.G., Trump, B.F., Wogan, G.N., & Harris, C.C. (1979),

Avantaggiato, G., Havenaar, R., & Visconti, A. (2004), 'Evaluation of the intestinal

Awad WA, Ghareeb K, Bohm J, & Zentek J (2010). Decontamination and detoxification

Baertschi, S.W., Raney, K.D., Shimada, T., Harris, T.M & Guengerich, F.P. (1989),

Ben-Ami R, Lewis RE, & Kontoyiannis DP (2010). Enemy of the (immunosuppressed) state:

Bennett, G.A., Wicklow, D.T., Caldwell, R.W., & Smalley, E.B. (1988). 'Distribution of

Bhat RV.(2008). Human health problems associated with current agricultural food production. Asia Pacific Journal of Clinical Nutrition. 17 Suppl 1:91-4. Bhat, R.V., Beedu, S.R., Ramakrihna, Y., & Munshi, K.L. (1989), 'Outbreak of trichothecene

Bily, A.C., Reid, L.M., Savard, M.E., Reddy, R., Blackwell, B.A., Campbell, C.M., Arnason,

Blumenthal, C.Z. (2004). 'Production of toxic metabolites in *Aspergillus niger*, *Aspergillus* 

Bowman, W.C., & Rand, M.J. (1990), '*Textbook of Pharmacology* (2 Eds)'. Blackwell Scientific

Bradburn, N., Coker, R.D., & Blunden, G. (1994). 'The aetiology of turkey X disease',

Chang, C.-H., Yu, F.-Y., Wu, T.-S., Wang, L.-T & Liu, B.-H. (2011). Mycotoxin Citrinin

Bresinsky, A., & Besl, H. (1990), 'A colour Atlas of Poisonous Fungi': A Handbook for

*Chemistry and Toxicology*, 42, pp 817-824.

Control Expo Risk Assess. 27(4):510-20.

Haematology. Aug;150(4):406-17

*Pharmacology*, vol 39, pp 214-228.

Publications London, pp. 1.85.

*Phytochemistry*, vol 35, pp 817.

Pharmacists, Doctors." Woolfe, London

*Sciences,* 119: 84-92.

Kashmir Valley, India', *Lancet*, vol 1, pp 35-37.

spectrometry', *Journal of Food Protection*, vol 67, pp 536-543.

3433.

122.

639-642.

'Metabolism of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya', *Cancer Research*, vol 47, pp 3430-

absorption of deoxynivalenol and nivalenol by an in vitro gastrointestinal model, and the binding efficacy of activated carbon and other adsorbent materials', *Food* 

strategies for the Fusarium mycotoxin deoxynivalenol in animal feed and the effectiveness of microbial biodegradation. Food Addit Contam Part A Chem Anal

'Comparison of rates of enzymatic oxidation of aflatoxin B1, aflatoxin G1, and sterigmatocystin and activities of the epoxides in forming guanyl-N7 adducts and inducing different genetic responses', *Chemical Research and Toxicology*, vol 2, pp114-

an update on the pathogenesis of Aspergillus fumigatus infection.British Journal of

trichothecenes and Zearelenone in *Fusarium graminearum*: Rotted corn ears grown in a controlled environment', *Journal of Agriculture and Food Chemistry,* vol 36, pp

mycotoxicosis associated with consumption of mould-damaged wheat products in

J.T., & Regnault, C. (2004), 'Analysis of *Fusarium graminearum* mycotoxins in different biological matrices by LC/MC', *Mycopathologia*, vol 157, pp 117-126. Bluhm, B.H., Cousin, M.A., &Woloshuk, C.P. (2004), 'Multiplex real-time PCR detection of

fumonisin-producing and trichothecenes in grains using gas chromatography-mass

*oryzae* and *Trichoderma reesei*: justification of mycotoxin testing in food grade enzyme preparations derived from the three fungi', Regulatory Toxicology and

Induced Cell Cycle G2/M Arrest and Numerical Chromosomal Aberration Associated with Disruption of Microtubule Formation in Human Cells. *Toxicological* 

(CYP3A4), with the simultaneous production of aflatoxin Q1. Conversely, low levels of aflatoxin B1 are activated by cytochrome CYP 1A2, with the simultaneous formation of aflatoxin M1.
